Skip to content

Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole A randomized controlled study

Document Type
Publications · Journal Article
Registered DB
SCIEScopus
Journal Ranking
JCR Q2Scopus Q1
Journal
MEDICINE98(20) · 2019
Citation
Web of Science 7Scopus 7
FWCI (Scopus)
0.59
JCR IF
JCR 2018 1.87
ISSN
0025-7974

Authors

  1. Ko, JihwanFirst authorDepartment of Internal Medicine, Pusan National University, School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Yangsan Hospital, Yangsan, Korea
  2. Kim, Su-jinDepartment of Internal Medicine, Pusan National University, School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Yangsan Hospital, Yangsan, Korea
  3. Kang, Dae-hwanCorresponding authorDepartment of Internal Medicine, Pusan National University, School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Yangsan Hospital, Yangsan, Korea
  4. Choi, Cheol-woongDepartment of Internal Medicine, Pusan National University, School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Yangsan Hospital, Yangsan, Korea
  5. Kim, Hyung-wookDepartment of Internal Medicine, Pusan National University, School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Yangsan Hospital, Yangsan, Korea
  6. Park Su BumDepartment of Internal Medicine, Pusan National University, School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Yangsan Hospital, Yangsan, Korea

Abstract

Background: Endoscopic submucosal dissection (ESD) is a standard procedure for treating gastric neoplasms. However, ESD causes larger artificial ulcers other than mucosal resection methods. We conducted this prospective randomized controlled study to evaluate the effect of stronger acid suppression on ESD ulcers caused by doubling the proton pump inhibitor (PPI) dose and compare the effects of 20-mg (standard dose) and 40-mg (double dose) esomeprazole (EswonampTM, Daewon Pharmaceutical Co., Ltd., Seoul, Korea) on ulcer healing. Methods: One hundred ninety-seven patients who underwent gastric ESD from July 2017 to December 2017 at Pusan National University Yangsan Hospital were enrolled and randomly assigned to the standard or double-dose group. Change in ulcer size from the day of ESD to 4 weeks after ESD and the scar-change rate were compared between the groups. Results: There were no significant differences in ulcer contraction (84.5% in 20mg group vs 86.3% in 40mg group, P=.91) or scar-change rate (30.9% vs 30.6%, P>.99) between the groups. In a multivariate analysis, initial ulcer size [ odds ratio (OR) 0.24; 95% confidence interval (CI) 0.11-0.50] and early gastric cancer (OR 0.22, 95% CI 0.08-0.58) were significantly associated with delayed ulcer healing. Conclusions: Both 40 and 20-mg esomeprazole have similar effects on ESD-induced ulcer area reduction, suggesting that strong acid suppression does not necessarily result in rapid artificial ulcer healing.

Keywords

endoscopic submucosal dissectionesomeprazoleproton pump inhibitorulcer healingPROTON PUMP INHIBITORSMUCOSAL RESECTIONRISK-FACTORSVONOPRAZANRABEPRAZOLEFAMOTIDINEOMEPRAZOLESUPERIORLANSOPRAZOLEMANAGEMENT

Identifiers

Scopus EID
2-s2.0-85066862815
WoS UID
000473676000086